newsfilter
← Latest News
GlobeNewswire·

Synthorx to Present THOR-809 Data at the American College of Rheumatology (ACR) Annual Meeting

SAN DIEGO, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, today...